VTP-1000 vaccine for adults with celiac disease
Part of Digestive system, Hormones & metabolism clinical trials.
This trial tests an experimental vaccine called VTP-1000 in adults with celiac disease. It may help calm the immune system so that accidentally eating gluten causes fewer or less severe symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with celiac disease through a blood test and a small intestine biopsy.
- You have the HLA-DQ2.5 gene type, which is common in people with celiac disease.
- You have been following a gluten-free diet well and your symptoms are under control.
- Your blood tests for celiac (tTG-IgA and DGP-IgG) are only slightly above normal or lower.
- You are not pregnant or breastfeeding.
- You do not have other serious health conditions that would interfere with the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the gut lining “tissues” are affected during gluten eating versus avoiding gluten in people with celiac disease. It may help researchers understand what drives healing and tissue damage in celiac disease.
This study tests an experimental medication for adults with celiac disease to see if it can protect against gluten exposure. You will need to follow a gluten-free diet and undergo a short, planned gluten challenge.
This trial compares different forms of gluten to see which one causes the strongest immune reaction in people with celiac disease. It may help doctors choose the best way to test gluten sensitivity in the future.
This study looks at how the immune system of children with celiac disease responds to a small amount of gluten. It may help researchers understand the disease better and find new ways to monitor it.
This trial tests whether tryptophan (a natural amino acid) can improve symptoms in people with celiac disease who still have symptoms despite following a gluten-free diet. It may help by supporting an internal body signal pathway researchers believe is impaired in some people with celiac disease.
This trial tests a new medicine, ZED1227, for people with celiac disease who still have symptoms despite eating gluten-free. The goal is to see if it helps reduce those symptoms.
Hear when a new Celiac Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.